Dr Ko is a multilingual German and Australian board-certified radiologist and clinician researcher with 20+ years international radiology experience.
She joined the Peter MacCallum Cancer Centre in 2017 and is affiliated with the University of Melbourne and the University of Bonn in Germany.
Dr Ko is subspecialist fellowship-trained in breast imaging (Melbourne, AUS), imaging research (Toronto, CAN) and paediatric radiology (Heidelberg, GER).
Since her experimental laboratory based medical doctorate (Mairbäurl, Effects of Hypoxia on NaK-ATPase in A549 epithelial lung cells), Dr Ko’s focus has been on harnessing clinical and research data to advance translational medicine. Her most recent research includes higher computational analysis, artificial intelligence, and radiomics to develop predictive imaging biomarkers.
In recognition of her contribution, Dr Ko was chosen as one of six finalists at the 19th Annual Research Australia Award 2022 (category: Data & Innovation).
She has won multiple national and international grants (e. g. Bonn-Melbourne Research Excellence Grant, Neuhauser Fellowship Award by theEuropean Soc. of Paediatric Radiology and the Children’s Hospital Boston, USA).
Her training/ work experience includes:
- The German Cancer Research Center (dkfz) Heidelberg, Germany
- University Hospital Heidelberg, Germany’s highest ranked German Medical Faculty
- Centre de Lutte Contre le Cancer, Montpellier, France
- Mount Sinai Hospital, NYC, USA
- The Hospital for Sick Children Toronto, Canada
- Royal Brisbane and Women’s Hospital Brisbane, Australia
- St. Vincent’s Hospital Melbourne, Australia
Dr Ko is an active member of RANZCR Advisory Committee on Artificial Intelligence and of the German Roentgen Society (DRG) Working Party Methodology and Research.
She is passionate about supporting aspiring researchers. Over recent years she has supervised several MD candidates as well as medical and biomedical research students. Recent awards of her mentees include 1st prize medical doctoral thesis – UoM 2020, 1st prize translational clinical research - COSA 2020, presentations- ARRS 2021, RSNA 2021, Röko 2022, COSA 2022, AGITG 2020, 2022.
A strong supporter of evidence-based medicine, Dr Ko believes in the strengths of multi-disciplinarity and inclusiveness as key ingredients of research innovation and impact.
Find more on Dr Ko’s profile on Google Scholar and on twitter: @HyunKoMD.